Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 13 - 24 items out of 27 results
ILCN article
Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?
ILCN article
The IASLC Pathology Committee Recommendations for the Use of Diagnostic Immunohistochemistry in Lung Cancer
ILCN article
Diagnostic Oncology: Reports from the IASLC Pathology Committee
ILCN article
The Rising Cost of Lung Cancer Therapies: What Are the Global Implications?
ILCN article
The Future Is Now: Pathology Is Going Digital
ILCN article
Enhancing Understanding of Testing Applications, Best Practices: A Q&A with Dr. Lynette M. Sholl
ILCN article
Low-Dose CT, ctDNA May Partner for Lung Cancer Detection
ILCN article
Award Lecture Highlights Tumor Evolution Through Liquid Biopsy
ILCN article
Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist
ILCN article
Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye
ILCN article
Recurrence Remains a Risk Even for Patients Diagnosed via Screening
ILCN article
New Data Support Continued Use of IASLC Staging Model for Mesothelioma
Pagination
First
First page
‹
Previous page
1
2
3
›
Next page
Last
Last page